Clinical Research Directory
Browse clinical research sites, groups, and studies.
Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer
Sponsor: Lahey Clinic
Summary
The goal of this clinical trial is to use urine tumor DNA (utDNA) as an indicator for non-muscle invasive bladder cancer to identify patients suitable for less frequent cystoscopy surveillance.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
56
Start Date
2025-01-01
Completion Date
2029-01-01
Last Updated
2025-09-22
Healthy Volunteers
No
Interventions
UroAmp Test (Convergent Genomics, Inc.)
Non-invasive genomic urine test that can reliably detect, monitor, and predict the risk of urothelial cancer or its recurrence, potentially before signs and symptoms develop or become detectable by historical standards of care.
Locations (1)
Lahey Hospital and Medical Center
Burlington, Massachusetts, United States